NCT02450877 - A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 12, 2015

Primary Completion Date

October 10, 2018

Study Completion Date

October 8, 2019

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG

Azacitidine

OTHER

Control Arm

Trial Locations (8)

Charite Berlin, Berlin

Medical School of Hannover, Hanover

Universitatsklinikum Essen, Essen

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt am Main

Universitatsklinik, Freiburg im Breisgau

Rigshospitalet, Copenhagen

VU University Medical Center, Amsterdam

Erasmus University Medical Center, Rotterdam